MedTrace Logo

Evaluation of a Rapid Diagnostic Device, CL Detect, for the Diagnosis of Cutaneous Leishmaniasis in Tunisia

NCT01769612 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 168

Last updated 2017-06-20

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to evaluate the sensitivity and specificity of CL Detect, in subjects with suspected CL in Tunisia.

Conditions

  • Skin Diseases, Parasitic

Interventions

OTHER

No Intervention

Sponsors & Collaborators

  • InBios International, Inc.

    collaborator INDUSTRY

  • Institut Pasteur of Tunis, Tunisia

    collaborator UNKNOWN

  • U.S. Army Medical Research and Development Command

    lead FED

Principal Investigators

  • Afif Ben Salah, MD PhD · Institut Pasteur de Tunis

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2013-08-31
Completion
2014-04-30

Countries

  • Tunisia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01769612 on ClinicalTrials.gov